car t-cells multiple myeloma: adam sperling, md, phd
Published 2 years ago • 1.2K plays • Length 31:00Download video MP4
Download video MP3
Similar videos
-
22:48
car t cells in multiple myeloma
-
1:37
blood cancer research: car-t in multiple myeloma
-
23:40
car t-cells in multiple myeloma
-
4:21
phase 1 study phe885 bcma-directed car-t cell therapy for rrmm | adam sperling, md, phd | asco 2023
-
2:44
what is car t-cell therapy? | dana-farber cancer institute
-
2:11
dr. adam sperling discusses care for multiple myeloma patients
-
1:48
mechanisms behind the loss of bcma in multiple myeloma & options for patients
-
0:36
promise of gprc5d-targeted car-t therapies in multiple myeloma
-
3:31
phe885, a novel bcma-directed car-t therapy for patients with r/r multiple myeloma
-
3:41
moving bcma-targeted agents to the frontline setting in myeloma & sequencing immunotherapies
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
0:39
car-t, bispecifics and mrd: how is treatment for multiple myeloma evolving?
-
7:17
updates on car t-cell therapy for myeloma
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:58
clonal hematopoiesis in multiple myeloma and implications for therapy
-
36:17
update on multiple myeloma treatment: kenneth c. anderson, md
-
18:54
2019 multiple myeloma symposium | cellular immunotherapy
-
5:46
adam d. cohen, md: expanding car t cells to treat myeloma